HYGROTON 50MG 50 MG
CHLORTHALIDONE : 50 MG · DIN 00010413 · NOVARTIS PHARMACEUTICALS CANADA INC
Health Canada status: CANCELLED POST MARKET
What is HYGROTON 50MG?
HYGROTON 50MG 50 MG contains CHLORTHALIDONE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00010413, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00010413 |
|---|---|
| Brand name | HYGROTON 50MG |
| Generic / active ingredient | CHLORTHALIDONE : 50 MG |
| Manufacturer | NOVARTIS PHARMACEUTICALS CANADA INC |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C03BA04 CHLORTALIDONE |
| AHFS class | 20:12.04.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Aug-1999 |
| Original market date | 1962-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C03BA04 CHLORTALIDONE. 7 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CHLORTHALIDONE | 50 MG | TABLET | APOTEX INC | MARKETED | DIN 00360279 |
| JAMP CHLORTHALIDONE | 12.5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02523795 |
| JAMP CHLORTHALIDONE | 25 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02523809 |
| JAMP CHLORTHALIDONE | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02523817 |
| MINT-CHLORTHALIDONE | 12.5 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02557126 |
| MINT-CHLORTHALIDONE | 25 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02557134 |
| MINT-CHLORTHALIDONE | 50 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02557142 |
| APO CHLORTHALIDONE TAB 100MG | 100 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00360287 |
| CHLORTHALIDONE 100MG TABLETS | 100 MG | TABLET | LABORATOIRES CONFAB INC | CANCELLED PRE MARKET | DIN 02232642 |
| CHLORTHALIDONE 50MG TABLETS | 50 MG | TABLET | LABORATOIRES CONFAB INC | CANCELLED PRE MARKET | DIN 02232633 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.